Author(s)

Jiaming Han, Kexin Wu, Bingyan Hu, Mingxi Zong

Corresponding Author

Jiaming Han

ABSTRACT

Acute myocardial infarction (AMI) accounts for approximately 16% of global mortality[1]. Young women, as a non-traditional high-risk group, suffers from AMI in a different way. In this review, we aim to study how to improve drug compliance in this subgroup of young female patients with acute myocardial infarction. We analyzed this matter from five perspectives: patient factors, socioeconomic factors, medical system factors, treatment factors, and technology factors. Educational level, as a patient factor, play an essential role. Results showed that patient's drug compliance is positively associated with level of education, yet health education will effectively close the gap. As for socio-economic factors, drug and follow-up visit to the hospital serve as burdens for those in poverty, furthermore, support from families and the society also play an integral role in improving prognosis. Medical system composes of education and the accessability of medical resources for patients. Nowadays, doctor-patient relationship in China is far from optimistic, therefore practical educational method should be put forward. As for medical resources scarcity, community-based clinics ought to exercise their responsibility. Treatment factors mainly consists of side effect and usage of the prescripted drugs. Patients’ fear of existing or non-existing side effect greatly affect compliance, and could be solved by education and better drug development. Polypill might be the answer for the complexity of treatment. In addition, we consider the feasibility of adopting new technologies among young female patients, and propose the use of smartphones for medication alerts to improve drug compliance among young female patients, etc.

KEYWORDS

Acute myocardial infarction, drug compliance, young women